JP2004534763A5 - - Google Patents

Download PDF

Info

Publication number
JP2004534763A5
JP2004534763A5 JP2002590936A JP2002590936A JP2004534763A5 JP 2004534763 A5 JP2004534763 A5 JP 2004534763A5 JP 2002590936 A JP2002590936 A JP 2002590936A JP 2002590936 A JP2002590936 A JP 2002590936A JP 2004534763 A5 JP2004534763 A5 JP 2004534763A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
less
composition according
tobramycin
spray
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002590936A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004534763A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/015999 external-priority patent/WO2002094217A1/en
Publication of JP2004534763A publication Critical patent/JP2004534763A/ja
Publication of JP2004534763A5 publication Critical patent/JP2004534763A5/ja
Pending legal-status Critical Current

Links

JP2002590936A 2001-05-18 2002-05-17 アミノグリコシド抗生物質の吸入投与のための方法および単位用量処方物 Pending JP2004534763A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29223401P 2001-05-18 2001-05-18
PCT/US2002/015999 WO2002094217A1 (en) 2001-05-18 2002-05-17 Methods and unit dose formulations for the inhalation administration of aminoglycoside antibiotics

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2009185305A Division JP2009269923A (ja) 2001-05-18 2009-08-07 アミノグリコシド抗生物質の吸入投与のための方法および単位用量処方物

Publications (2)

Publication Number Publication Date
JP2004534763A JP2004534763A (ja) 2004-11-18
JP2004534763A5 true JP2004534763A5 (https=) 2006-01-05

Family

ID=23123791

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2002590936A Pending JP2004534763A (ja) 2001-05-18 2002-05-17 アミノグリコシド抗生物質の吸入投与のための方法および単位用量処方物
JP2009185305A Pending JP2009269923A (ja) 2001-05-18 2009-08-07 アミノグリコシド抗生物質の吸入投与のための方法および単位用量処方物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2009185305A Pending JP2009269923A (ja) 2001-05-18 2009-08-07 アミノグリコシド抗生物質の吸入投与のための方法および単位用量処方物

Country Status (11)

Country Link
US (8) US20030143162A1 (https=)
EP (2) EP1320355B1 (https=)
JP (2) JP2004534763A (https=)
AT (1) ATE322249T1 (https=)
AU (1) AU2010210026A1 (https=)
CA (1) CA2447600C (https=)
DE (1) DE60210402T2 (https=)
DK (1) DK1320355T3 (https=)
ES (1) ES2261735T3 (https=)
PT (1) PT1320355E (https=)
WO (1) WO2002094217A1 (https=)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW465235B (en) 1998-09-17 2001-11-21 United Video Properties Inc Electronic program guide with digital storage
PT1320355E (pt) * 2001-05-18 2006-08-31 Chiron Corp Sistema para administracao de uma formulacao de tobramicina
US20040022740A1 (en) * 2001-07-10 2004-02-05 Baker William R. Macrolide formulations for inhalation and methods of treatment of endobronchial infections
JP2005502653A (ja) * 2001-08-20 2005-01-27 トランセーヴ・インコーポレーテッド 肺ガンの治療方法
JP2005514393A (ja) * 2001-12-19 2005-05-19 ネクター セラピューティクス アミノグリコシドの肺への供給
US7607436B2 (en) * 2002-05-06 2009-10-27 The Research Foundation Of State University Of New York Methods, devices and formulations for targeted endobronchial therapy
US8245708B2 (en) * 2002-05-07 2012-08-21 The Research Foundation Of State University Of New York Methods, devices and formulations for targeted endobronchial therapy
US9186322B2 (en) * 2002-08-02 2015-11-17 Insmed Incorporated Platinum aggregates and process for producing the same
JP2006502233A (ja) * 2002-08-02 2006-01-19 トランセーブ,インク. 白金凝集物およびその製造方法
AU2002953095A0 (en) * 2002-11-29 2002-12-19 Biota Scientific Management Pty Ltd Novel chemical compounds and their use
ES2552682T3 (es) 2003-03-10 2015-12-01 Merck Sharp & Dohme Corp. Agentes antibacterianos novedosos
WO2005037256A2 (de) * 2003-10-15 2005-04-28 Pari Gmbh Flüssige zubereitung enthaltend tobramycin
WO2005089448A2 (en) * 2004-03-18 2005-09-29 Transave, Inc. Administration of cisplatin by inhalation
US20070065522A1 (en) * 2004-03-18 2007-03-22 Transave, Inc. Administration of high potency platinum compound formulations by inhalation
EP2316419B1 (en) * 2004-05-17 2012-07-11 Gilead Sciences, Inc. Aerosolized fosfomycin/tobramycin combination for the treatment of bacterial respiratory infections
CN101001633A (zh) * 2004-05-21 2007-07-18 特兰萨夫公司 肺病和肺病前期病症的治疗
MXPA06014567A (es) 2004-06-18 2007-07-24 Novartis Vaccines & Diagnostic Metodo para el tratamiento de infecciones endobronquiales.
US20060246124A1 (en) * 2004-11-08 2006-11-02 Pilkiewicz Frank G Methods of treating cancer with lipid-based platinum compound formulations administered intraperitoneally
MX348936B (es) 2005-09-29 2017-07-03 Nektar Therapeutics Formulaciones de antibioticos, dosis unitarias, equipos y metodos.
AU2013206401B2 (en) * 2005-09-29 2016-06-23 Novartis Ag Antibiotic formulations, unit doses, kits, and methods
WO2007056264A2 (en) * 2005-11-08 2007-05-18 Transave, Inc. Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
WO2007056263A2 (en) * 2005-11-08 2007-05-18 Transave, Inc. Methods of treating cancer with high potency lipid-based platinum compound formulations administered intravenously
US9107824B2 (en) 2005-11-08 2015-08-18 Insmed Incorporated Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
US20070190181A1 (en) * 2005-11-08 2007-08-16 Pilkiewicz Frank G Methods of treating cancer with lipid-based platinum compound forumulations administered intravenously
US20070122350A1 (en) * 2005-11-30 2007-05-31 Transave, Inc. Safe and effective methods of administering therapeutic agents
HUE029994T2 (en) 2005-12-08 2017-04-28 Insmed Inc Lipid-based compositions of antiinfectives for treating pulmonary infections
WO2007070875A1 (en) * 2005-12-15 2007-06-21 Aerosol Science Laboratories, Inc. Treatment of active infections and related compositions
JP2008199905A (ja) * 2007-02-16 2008-09-04 Snow Brand Milk Prod Co Ltd 乳酸菌生残性向上剤
CN105732745A (zh) 2007-10-25 2016-07-06 森普拉制药公司 大环内酯类抗菌剂的制备方法
WO2009122345A1 (en) * 2008-04-02 2009-10-08 Nxp B.V. Method of manufacturing a semiconductor device and semiconductor device
AU2009308182B2 (en) * 2008-10-24 2016-05-19 Cempra Pharmaceuticals, Inc. Biodefenses using triazole-containing macrolides
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
US9480679B2 (en) 2009-09-10 2016-11-01 Cempra Pharmaceuticals, Inc. Methods for treating malaria, tuberculosis and MAC diseases
DK2550286T3 (en) 2010-03-22 2016-02-29 Cempra Pharmaceuticals Inc CRYSTALLINE FORMS OF A MACROLID AND APPLICATIONS THEREOF
CN105198944B (zh) 2010-05-20 2018-06-01 森普拉制药公司 制备大环内酯和酮内酯及其中间体的方法
CN103052392A (zh) * 2010-07-12 2013-04-17 赛利亚医药公司 通过氨基糖苷气雾给药治疗肺部感染
EP2613630A4 (en) 2010-09-10 2014-01-15 Cempra Pharmaceuticals Inc HYDROGEN BOND FOR THE PREPARATION OF FLUOROCHETOLIDES FOR THE TREATMENT OF DISEASES
US8826904B2 (en) 2011-07-12 2014-09-09 Cardeas Pharma Corporation Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis
CN103702663A (zh) 2011-07-12 2014-04-02 卡迪斯制药公司 治疗呼吸机相关肺炎(vap)和呼吸机相关气管(vat)支气管炎的阿米卡星和磷霉素组合的制剂以及方法和系统
MX2014011537A (es) 2012-03-27 2015-02-10 Cempra Pharmaceuticals Inc Formulaciones parenterales para la administracion de antibioticos macrolidos.
GB201208080D0 (en) 2012-05-09 2012-06-20 Norton Healthcare Ltd Tobramycin formulation
CN121606602A (zh) 2012-09-04 2026-03-06 埃莱森制药股份有限公司 用顺铂脂质复合物预防癌症的肺部复发
RU2018135921A (ru) 2012-11-29 2019-02-05 Инсмед Инкорпорейтед Стабилизированные составы ванкомицина
KR20150107793A (ko) 2013-01-11 2015-09-23 셀리아 파마슈티칼즈 에이피에스 폴리믹신, 조성물, 제조 방법 및 사용 방법
HK1217665A1 (zh) * 2013-03-14 2017-01-20 森普拉制药公司 用於治療呼吸道疾病的方法及其製劑
RU2015138797A (ru) 2013-03-15 2017-04-24 Семпра Фармасьютикалс, Инк. Конвергентные способы получения макролидных антибактериальных агентов
SMT202000516T1 (it) 2014-05-15 2020-11-10 Insmed Inc Metodi per trattamento di infezioni micobatteriche polmonati non tubercolari
EA201692569A1 (ru) 2014-07-09 2017-05-31 Кселлия Фармасьютикалз Апс Полимиксины с низкой степенью замещения и композиции, их содержащие
KR102494511B1 (ko) 2014-10-03 2023-01-31 셀리아 파마슈티칼즈 에이피에스 흡입 장치
SG11201702717XA (en) 2014-10-03 2017-04-27 Xellia Pharmaceuticals Aps Compositions
US10617703B2 (en) 2014-12-10 2020-04-14 Cmpd Licensing, Llc Compositions and methods for treating an infection
US11690815B2 (en) 2015-08-05 2023-07-04 Cmpd Licensing Llc Hyperkeratotic skin condition treatments and compositions
US11684567B2 (en) 2015-08-05 2023-06-27 Cmpd Licensing, Llc Compositions and methods for treating an infection
US11446236B2 (en) 2015-08-05 2022-09-20 Cmpd Licensing, Llc Topical antimicrobial compositions and methods of formulating the same
US10898491B2 (en) 2015-12-18 2021-01-26 Cmpd Licensing, Llc Compositions and methods for treating an infection
US10898455B2 (en) 2016-01-07 2021-01-26 Cmpd Licensing, Llc Urea cream formulations
US11278590B2 (en) 2015-08-05 2022-03-22 Cmpd Licensing, Llc Compositions and methods for treating nail infections
US11793783B2 (en) 2015-08-05 2023-10-24 Cmpd Licensing, Llc Compositions and methods for treating an infection
US9999604B2 (en) 2016-11-17 2018-06-19 Cmpd Licensing, Llc Compounded solutions of diclofenac and lidocaine and methods
US10525025B2 (en) 2016-11-17 2020-01-07 Cmpd Licensing, Llc Compounded compositions and methods for treating pain
EP3773505B1 (en) 2018-03-30 2026-04-29 Insmed Incorporated Methods for continuous manufacture of liposomal drug products
WO2019213398A1 (en) 2018-05-02 2019-11-07 Insmed Incorporated Methods for the manufacture of liposomal drug formulations
WO2020163416A1 (en) * 2019-02-05 2020-08-13 Mylan Inc Devices and methods for tobramycin inhalation treatment

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3993223A (en) 1974-07-25 1976-11-23 American Home Products Corporation Dispensing container
US4502616A (en) 1982-01-04 1985-03-05 Health Care Concepts, Inc. Single use vial
GB8801655D0 (en) 1988-01-26 1988-02-24 Waverley Pharma Ltd Ampoules
EP0326529B1 (en) 1988-01-28 1992-12-30 Lameplast S.R.L. A strip of phials for pharmaceuticals, cosmetics and other products
GB8802349D0 (en) 1988-02-03 1988-03-02 Waverley Pharma Ltd Ampoule with luer
DE3916840A1 (de) 1988-09-21 1990-03-29 Bernd Hansen Ampulle
US5409125A (en) 1989-12-11 1995-04-25 Aktiebolaget Astra Unit dose container
CA2027690A1 (en) 1990-10-18 1992-04-19 Christian Laing Plastic ampul
FR2687066A1 (fr) 1992-02-06 1993-08-13 Oreal Ampoule autocassable.
US5508269A (en) 1994-10-19 1996-04-16 Pathogenesis Corporation Aminoglycoside formulation for aerosolization
US5758637A (en) * 1995-08-31 1998-06-02 Aerogen, Inc. Liquid dispensing apparatus and methods
US6083922A (en) 1996-04-02 2000-07-04 Pathogenesis, Corp. Method and a tobramycin aerosol formulation for treatment prevention and containment of tuberculosis
PL348812A1 (en) 1998-12-17 2002-06-17 Pathogenesis Corp Method for the treatment of severe chronic bronchitis (bronchiectasis) with an aerosolized antibiotic
SE9902627D0 (sv) * 1999-07-08 1999-07-08 Siemens Elema Ab Medical nebulizer
DE19953317C1 (de) 1999-11-05 2001-02-01 Pari Gmbh Inhalationsvernebler
PT1320355E (pt) 2001-05-18 2006-08-31 Chiron Corp Sistema para administracao de uma formulacao de tobramicina

Similar Documents

Publication Publication Date Title
JP2004534763A5 (https=)
KR101357508B1 (ko) 투약 및 건식 분무용 장치
KR102012418B1 (ko) 에어로졸화에 의한 토브라마이신의 투여에 의한 폐 감염의 치료
AU642037B2 (en) Device for mouth-inhaling aerosol medicaments
CA2464250C (en) Kit for the preparation of a pharmaceutical composition
EP2186508A3 (en) Methods and unit dose formulations for the inhalation administration of aminoglycoside antibiotics
JP2011520911A5 (https=)
JP2009269923A5 (https=)
CA2406119A1 (en) Pharmaceutical formulations for dry powder inhalers in the form of hard-pellets
CA2468958A1 (en) Pulmonary delivery of aminoglycosides
AU2001275368A1 (en) Highly efficient delivery of a large therapeutic mass aerosol
JP2008536546A5 (https=)
JP2003525081A5 (https=)
CA2425489A1 (en) Therapeutic use of aerosolized s-nitrosoglutathione in cystic fibrosis
TNSN06277A1 (en) Pharmaceutical formulations for dry powder inhalers comprising a low-dosage strength active ingredient
CA2564546A1 (en) Aerosolized fosfomycin/aminoglycoside combination for the treatment of bacterial respiratory infections
US20130014759A1 (en) Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (vap) and ventilator associated tracheal (vat) bronchitis
Subramani et al. The role of pulmonary drug delivery in modern therapeutics: an overview
Kuhn Pharmaceutical considerations in aerosol drug delivery
US20130291860A1 (en) Method For Treating Cystic Fibrosis with Inhaled Denufosol
US20210046258A1 (en) Method and apparatus for producing fine concentrated aerosol
JP2005531604A5 (https=)
CZ287114B6 (en) Therapeutic preparation in the form of aerosol and use of gas mixture
KR20230035518A (ko) 선천적 면역 반응을 생성하기 위한 퀴닌과 그의 용도
WO2021158851A1 (en) Pharmaceutical formulation containing remdesivir